Streetbeat News

Analyst Ratings

SOVO

Needham analyst Matt McGinley has downgraded Sovos Brands (NASDAQ:SOVO) from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 4:32 pm

GTBP

EF Hutton analyst Tony Butler has reiterated a 'Hold' rating on GT Biopharma (NASDAQ:GTBP) and maintained a $2 price target.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 4:31 pm

MCD

A significant amount of unusual options activity has been observed for McDonald's (NYSE:MCD), with a majority of investors taking a bearish stance. The price range targeted by these investors over the last three months is from $240.0 to $310.0. The current price of MCD is up 1.25% at $290.61. Several financial institutions have maintained their positive ratings on McDonald's, with price targets ranging from $315 to $343.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:30 pm

NKTR

Mizuho analyst Mara Goldstein has reiterated a Neutral rating on Nektar Therapeutics (NASDAQ:NKTR) and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 4:30 pm

KRYS

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Krystal Biotech (NASDAQ:KRYS) and maintained a price target of $139.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 4:29 pm

RHP

Deutsche Bank analyst Chris Woronka has maintained a 'Buy' rating on Ryman Hospitality Props (NYSE:RHP) and raised the price target from $128 to $129.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 4:29 pm

PTN

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Palatin Techs (AMEX:PTN) and maintained a $70 price target.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 4:29 pm

DLR

RBC Capital analyst Jonathan Atkin has maintained an 'Outperformer' rating on Digital Realty Trust (NYSE:DLR) and raised the price target from $125 to $140.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 4:28 pm

IKNA

HC Wainwright & Co. analyst Andres Maldonado has reiterated a 'Buy' rating on Ikena Oncology (NASDAQ:IKNA) and maintained a price target of $18.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 4:28 pm

WMS

Deutsche Bank analyst Joe Ahlersmeyer maintains a 'Buy' rating on Advanced Drainage Systems (NYSE:WMS) and raises the price target from $131 to $162.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 4:27 pm